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Deﬁning which cells become infected with simian immunodeﬁciency virus (SIV) in vivo should assist in
unravelling the pathogenesis of human immunodeﬁciency virus (HIV)/SIV infection. HIV/SIV infection
of CD4þ T cells resulted in down-regulation of CD3 and CD4 surface molecules in vitro, however this
phenomenon is poorly characterised in vivo. Intracellular SIV p27 was studied by ﬂow cytometry
in serial blood samples and lymph node samples during acute infection of 17 SIVmac-infected pigtail
macaques. Two weeks after infection, a mean of 5676.8% the p27þ cells were lymphocytes negative
for surface CD4 and CD3, and indeed the highest proportion of SIV infected cells were found in the small
subset of CD3LoCD4CD8 lymphocytes, indicating that infection has lead to down-regulation of these
markers in vivo. Furthermore, the relative amount of SIV p27 within lymphocytes (based of mean
ﬂuorescence intensity) was higher in CD3LoCD4 and CD3 infected cells than in CD3þ or CD4þ p27þ
populations, consistent with greater viral production in CD4þ T cells down-regulating CD3 and CD4
molecules. The CD3CD4 infected cells expressed T cell markers CD2 and CD5 and were negative for
monocyte, NK and B cell markers. The majority of infected cells were CD28þCD95þ central memory T
cells. Surprisingly, p27þ blood lymphocytes were mostly negative for activation markers CD25 and
CD69, but most of the infected lymph nodes cells were activated. Our results characterise productively-
infected macaque lymphocytes in vivo. The high proportion of SIV-infected lymphocytes that are
CD3CD4 has important implications for the in vivo study of pathogenesis of SIV/HIV infections.
& 2012 Elsevier Inc. All rights reserved.Introduction
A better understanding of how HIV spreads in vivo should
ultimately lead to more reﬁned strategies to treat or prevent
infection. In vitro studies indicate that HIV or SIV infection of
CD4þ T cells results in down-regulation of CD4 from the cell
surface, and that CD3 is also down-regulated by HIV-2 and most
SIV strains (Aiken et al., 1994; Foster and Garcia, 2008; Levesque
et al., 2004; Sanfridson et al., 1994; Schindler et al., 2006).
Similarly MHCI and II, and CD28 are also down-regulated by
HIV or SIV infection (Bell et al., 2001; Schwartz et al., 1996;
Swigut et al., 2001). Although long-established in vitro, very few
studies have addressed CD3 and CD4 down-regulation in vivo.
Lentiviral down-regulation of cell surface CD4 is best char-
acterised in HIV-1-infected T cell lines. HIV-1 uses at least three
mechanisms to reduce CD4 expression on the cell surface: the Nefll rights reserved.
. Winnall),
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edu.au (R. De Rose),accessory protein down-regulates surface CD4 by accelerating its
endocytosis, the envelope gp160 precursor retains newly synthe-
sised CD4 in the endoplasmic reticulum (ER) and the Vpu
accessory protein induces degradation of CD4 complexed to
Env-gp160 in the ER (Chen et al., 1996; Craig et al., 1998;
Levesque et al., 2004; Martin and Nayak, 1996). The conservation
of CD4 down-regulation across HIV and SIV species, as well as the
multiple mechanisms involved, indicate the importance of CD4
down-regulation to HIV immunopathogenesis. Indeed, mutations
in SIV or HIV-1 Nef which abrogate Nef’s ability to down-regulate
CD4 in vitro, lead to a signiﬁcant reduction in viral load in infected
subjects (Deacon et al., 1995; Iafrate et al., 2000).
Nef is also able to down-regulate CD3, along with the T cell
receptor (TCR), from the cell surface in vitro (Schindler et al., 2006)
but the mechanism by which this occurs is not as well characterised
as that for CD4 down-regulation. Nef-mediated down-regulation of
CD3, however, appears to have been lost in the lentiviral lineage that
gave rise to HIV-1, but is maintained in most SIVs well as HIV-2
(Schindler et al., 2006). As for CD4, CD3 down-regulation is described
in vitro, but in vivo evidence for this phenomenon is limited to two
publications (Friedrich et al., 2010; Reynolds et al., 2010).
There is a body of evidence, primarily using PCR-based studies
of sorted CD4þ T cells, that HIV preferentially infects particular
W.R. Winnall et al. / Virology 428 (2012) 11–2012subsets of T cells in vitro and in vivo. These studies have shown that
activated CD4 T cells, central memory CD4 T cells, and T cells
expressing the a4b7 integrin all support HIV infection or replication
more efﬁciently that naı¨ve T cells or a4b7T cells (Brenchley et al.,
2004; Cayota et al., 1993; Centlivre et al., 2011; Heeregrave et al.,
2009; Kader et al., 2009; Schnittman et al., 1990). HIV infection is
also detected in CD4þ NK cells and in some CD8þ T cells (Bernstein
et al., 2009; Huete et al., 2001; Mercure et al., 1993). Deﬁning theFig. 1. Flow cytometric detection of SIV-infected (p27þ) peripheral blood and lymph no
CD3 and CD4. (A) Peripheral blood and lymph node cell populations were gated for ly
aggregates were excluded (2nd panel). The remaining cells were gated to select CD8 ly
4th panels). The peripheral blood cells (B) and lymph node cells (C) within these gates w
ﬁrst panel shows the background from a control sample taken at day 0 for blood (popu
lymph nodes where anti-p27 was omitted from the staining mix. The remaining panels
each of these populations of peripheral blood lymphocytes which were p27þ at day 14
of p27 staining (where detected) for each of these populations at day 14 of infection.characteristics of infected cell populations in vivo based on CD4þ T
cell populations may be problematic when these cells down-
regulate CD4 T cell expression, and infected cell populations with
implications for immunopathogenesis may be overlooked.
Macaque SIV models permit knowledge of the timing of
infection, and the pigtail macaque exhibits uniform and rapid
progression to disease (Klatt et al., 2011). The sampling of blood
at regular intervals during acute infection of macaques allowsde cells and comparison of infection in populations with differing levels of surface
mphocytes by forward (FSA) and side-scatter (SSA) properties (1st panel) and cell
mphocytes with CD3 , CD3Hi and a small population for CD3Lo expression (3rd and
ere subdivided into CD4þ and CD4 populations in which p27þ was detected. The
lation containing all CD8 lymphocytes) and a ﬂuorescence minus one (FMO) for
show p27þ cells in the CD3 , CD3Lo and CD3Hi populations. (D) The proportion of
of infection over each infected animal. (E) The median ﬂuorescence intensity (MFI)
The number of animals in each group in (D) and (E) were all n¼12.
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study of HIV-infected individuals. Recent studies in SIV-infected
rhesus macaques illustrated the loss of cell surface CD3 and CD4
molecules in vivo, in lymphocytes from lymph nodes after 19
weeks of infection (Friedrich et al., 2010; Reynolds et al., 2010).
Herein, we characterise SIV-infected cells during acute SIVmac
infection of 17 pigtail macaques. We show that a larger fraction of
Gag expressing cells, and higher levels of viral antigens, are
present in cell populations which had down-regulated CD3 and
CD4 molecules.Fig. 2. Kinetics of p27 expression and viral load over time. (A) Comparison of the
proportion of p27þ among all CD8 lymphocytes from serial blood samples over
the acute infection period. Statistical signiﬁcance was determined using a Friedman
test across all 7 time-points and individual comparisons were made usingWilcoxon
Signed Rank tests. (B) Comparison of the mean proportion of p27þ cells (left y-axis)
with the viral load (right y-axis). Shown are mean and SEM for n¼12 animals. Lines
are a guide for the eye only.Results
CD3 and CD4 down-regulation in SIV-infected lymphocytes in vivo
To assess the phenotype of SIV-infected cells in vivo we
infected 17 pigtail macaques with SIVmac239 or SIVmac251 and
studied serial blood and lymph node samples (day 14 only) by
ﬂow cytometry. Gated CD8 lymphocytes were divided into
CD4þ and CD4 populations and into CD3Hi, CD3 and a small
subset of CD3Lo cells lying between the CD3Hi and CD3 popula-
tions (Fig. 1A). Samples taken at day 0 as well as control samples
with all antibodies except anti-p27 (FM0) were used to acurately
gate on p27þ cells (Fig. 1B and C). Two weeks after infection,
small numbers of CD3HiCD4þ cells expressing intracellular p27
were observed in both blood (Fig. 1B) and lymph node (Fig. 1C)
preparations, with generally low ﬂuorescent intensity of p27
expression; very few CD3HiCD4 cells were found to express
p27. A mean of 56% (n¼11, SEM 6.7%) of the p27þ cells were
negative for both CD3 and CD4 (data not shown). We found a
signiﬁcantly greater proportion of p27þ cells in the CD3CD4
than the CD3HiCD4 population (Fig. 1D) (F(5,59)¼31.42,
po0.001). These CD3 p27-expressing cells also had signiﬁcantly
higher ﬂuorescent intensity of p27 than the p27þCD3HiCD4þ
population, suggesting higher amounts of p27 within these cells
(Fig. 1E) (F(4,46)¼27.73, po0.001). Across all the animals with
p27þ cells identiﬁed at day 14, we found the highest proportion
of cells expressing p27 in the small CD3Lo populations (Fig. 1D).
Time course of p27þ cells following acute infection
We studied the kinetics of p27 expression in peripheral blood
cells over time. The peak of p27-expressing cells was 14 day
after infection (Fig. 2A). The proportion of p27þ cells 14 day after
infection was signiﬁcantly greater than 8, 17 or 22 days after
infection (Friedman Test across all 7 time-points w2(6, n¼13)¼
43.543 and Wilcoxon Signed Rank Tests as indicted in the ﬁgure).
The peak in p27-expressing cells coincided with the peak in
plasma viral RNA at or around this time (Fig. 2B). There was a
rapid fall off in numbers of infected cells in the blood by 22 day
after infection, when they were rarely detectable. Lymph node
mononuclear cells had relatively high proportions of p27þ cells 14
days after infection (mean¼0.532%, range¼2, Fig. 1.C) but fewer
were detected 4 weeks after infection (0.285% in one animal, data
not shown). There were no dramatic shifts in p27þ cells between
the different CD3þ / or CD4þ / populations over time, consistent
with the rapid turnover of infected cells (data not shown).
CD3CD4 SIV-infected cells bear central memory T cell markers
Cells that express intracellular p27 but lack CD3 and CD4
markers could be clearly distinguished from lineages other than
CD4þ T cells. In fresh whole blood or thawed PBMC samples from a
subset of SIV-infected animals we counter stained the p27þ cells
from blood and lymph nodes at day 14 with various cell surfacemarkers. The CD14þ (monocyte) populations were uniformly
negative for p27þ cells (Fig. 3A). The majority of the p27þ cells
stained positively for CD2 and CD5 (Fig. 3B–D), indicating that they
were T cells. CD2 is also found on the surface of B cells and NK cells
and CD5 is found on the surface of a subset of B-cells. We therefore
demonstrated that the majority of infected CD2þ cells were CD20
(92%, Fig. 3B), therefore unlikely to be B-cells, and negative for CD16
and CD56, which together identify NK cells and sub-populations
of monocytes/granulocytes (Reeves et al., 2010) (80%, Fig. 3C).
Furthermore, the infected CD5þ cells were also CD20 , indicating
that they were not B-cells (67.8%, Fig. 3D).
Most actively and latently HIV-infected CD4 T cell populations
identiﬁed by PCR techniques are central memory T cells (Brenchley
et al., 2004). In the macaque, these central memory cells bear the
surface markers CD28 and CD95 (Pitcher et al., 2002). Notably, the
loss of CD28þCD95þ central memory CD4 T cells predicts progres-
sion to AIDS in SIV-infected rhesus macaques (Letvin et al., 2006).
We therefore counter-stained macaque blood and lymph node
samples from the acute SIV infection period (days 9 to 22 and
day 14 only for lymph nodes) with CD3/4/8/28/95 surface markers
and intracellular p27 to determine the proportion of central
memory T cells among the infected population. CD8 staining was
used to exclude CD8þ T cells form these analyses. A median of
35.8% (range: 18% to 46% over 5 time-points) of peripheral blood
and 47% of lymph node CD4þ T cells (Day 14 only) were
CD28þCD95þ central memory T cells (Fig. 4A and B, ﬁrst column).
In contrast, a median of 66.7% (range: 38–72%) of the peripheral
blood p27þ cells were CD28þCD95þ and median of 77% (range:
69–84%) of infected lymph node lymphocytes were CD28þCD95þ
Fig. 3. The CD3CD4 infected cells express surface T cell markers but not markers for monocytes, B lymphocytes or NK cells. (A) Comparison of CD14 surface expression
on CD8 peripheral blood cells which were either p27þ and p27 . The left panel is a ﬂuorescence minus one control (FM0) where only anti-p27 was omitted, showing
some non-speciﬁc ﬂuorescence from CD14 positive cells (top right quadrant). The right panel shows p27-labelled cells in the CD14 quadrant only (bottom right
quadrant). Analysis of CD2 versus CD20 labelling (B), CD2 versus CD16a/CD56 labelling (C) and CD5 versus CD20 labelling (D) of thawed PBMCs from day 14 of infection. For
each row, the populations in the left panels are all live PBMCs, used to set the gates, in the middle panel are CD3þCD4þ T cells and in the right panel are p27þ PBMCs.
Results are representative of the 2 animals examined.
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memory T cells were over represented in the infected cell popula-
tion. Also apparent were a corresponding decrease in the proportion
of the CD28þCD95 naı¨ve T cells (from median of 58% to 9.5%) and
possibly a small increase in the proportion of CD28CD95þ effector
T cells (from median of 9.6%–24%) among the infected population
compared to the total CD4þ T cells population. When CD3CD4
infected cells (third column) were compared to CD3þCD4þ
infected cells (fourth column), the double negative population
was more likely to be CD28 than double positive infected cells,identifying them as effector memory T cells. However, infection can
also lead to down-regulation of CD28, making this change in CD28
expression difﬁcult to interpret (Bell et al., 2001).
Mucosal homing integrin (a4b7) and activation markers expressed
by SIV-infected cells
The ability to individually detect SIV-infected cells by ﬂow
cytometry allows us to further phenotype these cells for mucosal
homing integrins and activation markers. The mucosal homing
Fig. 4. Infected peripheral blood and lymph node cells express central memory T cell markers. CD28 and CD95 expression on CD8 peripheral blood lymphocytes (A) and
lymph node cells (B) on day 14. In each row, the populations in the ﬁrst panel are CD3þCD4þ lymphocytes used to set the gates. In the 2nd panel the populations are
p27þCD8 lymphocytes. The populations in the next two panels are p27þ lymphocytes which were CD3CD4 and CD3þCD4þ as indicated. Tn refers to naı¨ve, Tcm to
central memory and Tef to effector memory T cells. (C) The proportions of naı¨ve T cells (white circles), central memory T cells (black circles) or effector memory T cells
(grey circles) among CD8 lymphocytes populations: CD3þCD4þ , p27þ , p27þCD3CD4 and p27þCD3þCD4þ as indicated under the x-axis. Two animals over 4 to
5 time-points are shown which indicates a trend, but no statistics could be done to analyse these data. Lines depict medians for each group.
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gut (Kilshaw and Murant, 1991). When we co-stained peripheral
blood for both p27 and b7 at day 14 of SIV infection we found that,
although the b7Hi population was somewhat enriched for p27þ
cells, the majority of the infected cells were b7Lo or negative
(Fig. 5A). These results were consistent over 2 animals and 5 time-
points (9–22 day post infection) (Fig. 5B). Within the lymph node
cells few b7 positive cells were detected, as expected, since they do
not migrate to this region in substantial numbers (data not shown).
The proportions of b7-high or low populations among infected
cells did not differ greatly when CD3CD4 infected cells were
compared to CD3þCD4þ infected cells (data not shown).
Activated CD4þ T cells are ready targets for productive HIV/SIV
infection and in vitro experiments show higher levels of productive
infection are achieved in activated compared to unactivated CD4þ
T cells (McDougal et al., 1985; Nabel and Baltimore, 1987). We
studied the surface activation markers CD25 and CD69 in p27þ
cells and in p27 CD3þCD4þ lymphocytes in blood (9–22 day post
infection) and lymph nodes 14 day after SIV infection. Peripheral
blood contained only a small proportion of CD25þ/CD69þ CD4 T
lymphocytes (usually less than 10%) and the proportions of p27þ
cells that expressed activation markers were consistently similar to
the p27 cells over 2 animals and 5 time-points (Fig. 5C and E).
However, in lymph node mononuclear cells, the overall levels of
activated lymphocytes were higher than in the blood (25%) and
the p27þ cells were highly enriched for expression of the activa-
tion markers (75%) (Fig. 5D and F). The proportions of activated
infected cells did not differ greatly when CD3CD4 infected cells
were compared to CD3þCD4þ infected cells (data not shown).SIV infection of CD8þ T cells
CD4 is generally regarded as an essential primary receptor for
HIV/SIV infection of cells, although there have been older reports
of HIV infection of peripheral blood CD8 T cells (Livingstone et al.,
1996). Since small populations of CD4þCD8þ lymphocytes circu-
late, we analysed whether we could detect p27 expression in
CD8þ lymphocyte fractions 14 day after infection. We gated on
CD8þ lymphocytes and analysed cells for CD3 and CD4 expres-
sion as well as p27 expression (Fig. 6A). In 12 of the animals
studied we detected low level but deﬁnite p27 expression in
CD8þ lymphocyte fractions (Fig. 6A and B). The proportions
of p27þ expression in CD8þ lymphocytes were consistently less
than those observed in CD8 lymphocytes. Interestingly, the
pattern of infection was similar to the CD8 fraction studied
above, i.e. the highest proportion of infected cells was detected in
the CD4CD3 T cells, however the differences between these
proportions were not statistically signiﬁcantly (Kruskal Wallis
test: w2(3, n¼48)¼6.11, p¼0.106). These data suggest that SIV is
able to infect CD4þCD8þ double positive T cells resulting in
down-regulation of CD4 and CD3, as for CD4þCD8 T cells.Discussion
The precise identiﬁcation of SIV-infected cell populations has
important implications for HIV and SIV pathogenesis studies.
Many previous studies detecting SIV/HIV-infected cells in vivo
start with the assumption that CD3þCD4þ T cells are the primary
Fig. 5. Mucosal homing integrin (b7) and activation marker expression by infected peripheral blood and lymph node cells on day 14. (A) Gating strategy to detect b7
expression compared to side scatter properties (SSA) in a ‘‘ﬂuorescence minus 2’’ control (FM2) where anti-p27 and anti-b7 were omitted (left hand panel), in CD3þCD4þ
lymphocytes (middle panel) and in CD8p27þ lymphocytes (right panel). Gates were designed to detect b7 , b7Lo and b7Hi cells. (B) The proportions of CD3þCD4þ
lymphocytes (black circles) and CD8p27þ lymphocytes (white circles) which were b7 , b7Lo or b7Hi cells. Two animals over 4 to 5 time-points are shown which indicates
a trend, but no statistics could be done to analyse these data. Lines depict medians for each group. (C and D) Gating strategy to detect activated (CD25þ and/or CD69þ)
cells among peripheral blood lymphocytes (C) and lymph node cells (D). Expression of CD25/CD69 compared to side scatter properties (SSA) in CD3þCD4þ lymphocytes
(left panel) and in CD8p27þ peripheral blood lymphocytes (right panel). (D) Expression of CD25/CD69 in the same populations of lymph node cells. (E) The proportions of
CD3þCD4þ lymphocytes (black circles) and CD8p27þ lymphocytes (white circles) which were unactivated (CD25CD69) or activated (CD25þ and/or CD69þ) cells.
Two animals over 4 to 5 time-points are shown which indicates a trend, but no statistics could be done to analyse these data. Lines depict medians for each group. Results
are representative of 2 animals over 4 time-points examined. (F) The proportions of CD3þCD4þ lymph node cells and CD8p27þ lymph node cells which were
unactivated or activated cells in two animals at one time-point (14 day after infection).
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Centlivre et al., 2011; Heeregrave et al., 2009; Mattapallil et al.,
2005). In the present study, intracellular staining of peripheral
blood and lymph node cells for the SIV capsid protein p27
identiﬁed productively-infected cells, of which approximately
half lacked surface CD3 and CD4. Although it is likely true that
CD3þCD4þ T cells are the primary lymphocyte targets of SIV
infection, our studies actually indicate that a large proportion of
infected cells in vivo had down-regulated surface CD4 and CD3.
That these infected CD3CD4 cells were once T cells is sup-
ported by the detection of other T cell markers on their cell
surface (CD2 and CD5) and the absence of other lineage markers:
CD14 which identiﬁes monocytes, CD20 which identiﬁes B cells,
and CD56/CD16a which together identify NK cells in macaques, as
well as some CD56þ monocytes and CD16þ granulocytes (Reeves
et al., 2010). It is important to note that latently-infected cells
would not be part of the infected population characterised in ourstudy, and that some CD4þ cells which stain positively for p27
may have virus attached to cell surface CD4 but not internalised.
The apparent loss of surface CD3 and CD4 from SIV-infected
cells indicates that infection has lead to down-regulation of these
proteins from the cell surface, however we have not formally
demonstrated down-regulation events in vivo. During experi-
ments where this was attempted, we discovered a considerable
amount of intracellular expression of these markers in cells with
concomitant surface staining. This obscured any increase in
intracellular levels in infected cells following removal of these
proteins from the cell surface (data not shown). Down-regulation
of CD3 and CD4 by SIV infection is consistent with numerous
studies in cultured HIV or SIV-infected cells (Aiken et al., 1994;
Foster and Garcia, 2008; Levesque et al., 2004; Sanfridson et al.,
1994; Schindler et al., 2006), two similar macaque experiments
(Friedrich et al., 2010; Reynolds et al., 2010) but not with an
earlier study (Schnittman et al., 1989). One study reported that
Fig. 6. Flow cytometric detection of p27þ cells in the peripheral blood CD8þ
lymphocyte population. (A) CD8þ peripheral blood lymphocytes were divided
into CD3 and CD3þ populations (gating strategy not shown). Staining for p27
and CD4 was compared in the CD3CD8þ lymphocyte population (left panel) and
CD3þCD8þ lymphocyte population (right panel). (B) The proportion of each of
these populations of CD8þ lymphocytes which were p27þ at day 14 of infection
over each of the 12 animals which had infected CD8þcells.
W.R. Winnall et al. / Virology 428 (2012) 11–20 1790% of SIV-infected lamina propria cells were CD4þ cells, but
these immunohistochemistry results demonstrated CD4 protein
expression which may have been on the surface or intracellular
(Li et al., 2005). We propose that, at least initially, these markers
would ﬁrst be removed from the cell surface then degraded, based
on cell culture experiments (Foster and Garcia, 2008; Greenberg
et al., 1997; Sanfridson et al., 1994). However, it was interesting
to note that the highest proportion of SIV-infected cells was in the
populations with low expression of surface CD3; cells which are
likely to be in the process of down-regulating this molecule.
Furthermore, higher levels of the p27 protein (measured by
higher MFI, Fig. 1E) were detected within infected cells with no
surface CD3 and CD4. Staining of CD4 with a brighter ﬂuoro-
chrome might reveal low levels of surface CD4, indeed Reynolds
(2010) found that a CD4Lo population were also p27þ using a
brighter conjugate of CD4. We speculate that the CD3CD4
population of cells had been infected for a longer period of time,
allowing time for both down-regulation of these molecules and
higher levels of viral antigen expression.
The biological relevance of CD3 and CD4 down-regulation
events has not been determined, but there are many suggested
reasons for this phenomenon. CD4 down-regulation from the
surface is suggested to aid release of the virus by diminishing
the ability of CD4 to bind to gp120 on the budding virion, to stop
CD4 being incorporated into the virion membrane and to reduce
the possibility of multiple infections which might kill the cell too
rapidly (Das and Jameel, 2005; Levesque et al., 2004). Interest-
ingly, the extent of CD3 down-regulation in vitro by differing
Nef alleles inversely correlated with the severity of SIV infection
of sooty mangabeys, indicating that CD3 down-regulation was
beneﬁcial to the host (Schindler et al., 2008). CD3 down-regula-
tion was proposed to prevent activation-induced cell death in this
model. The present study does not support a beneﬁt to the host of
CD3 down-regulation, since considerable loss of surface CD3 wasdetected in the pigtail macaque model in which progression to
AIDS is relatively rapid (Klatt et al., 2011). At least in the lymph
nodes, considerable activation of CD3 infected cells indicates
minimal resistance of SIV-infected lymphocytes to activation in
our model.
Most of the CD3CD4 infected cells expressed CD2 and CD5
indicating that they were once T cells. Further evidence of their
identity comes from CD28 expression (expressed on naı¨ve and
central memory T cells), as well as a lack of markers for mono-
cytes, NK cells and B-cells. Interestingly a very small proportion of
cells were positive for CD16/CD56, indicating that they could be
infected NK cells, consistent with in vitro studies where HIV could
infect CD4þ NK cells in culture, leading to CD4 down-regulation
(Bernstein et al., 2009). We also detected small populations of
CD8þ lymphocytes that had intracellular p27 expression, consis-
tent with some previous studies (Flamand et al., 1998; Huete
et al., 2001; Marodon et al., 1999). These cells were generally
either CD8þCD4þ double positive cells or had a pattern of CD4
and CD3 down-regulation very similar to that observed in the
CD8 population. These results are consistent with the hypoth-
esis that CD8þCD4þ double positive T cells can be infected with
SIV in vivo and that, as for CD4þ T cells, the infection results in
down-regulation of CD3 and CD4. A previous study characterising
double positive cells from rhesus macaques blood showed them
to be mostly central memory cells (CD28þCD95þ) with similar
levels of activation to blood CD4þ T cells (approximately 20%
CD25þCD69þ) (Pahar et al., 2006). It is interesting to note that
double positive T cells are abundant in the intestinal lamina
propria of rhesus macaques. These intestinal double CD4þCD8þ
T cells have a memory phenotype, are highly activated and
express high levels of the HIV/SIV co-receptor CCR5 (Pahar
et al., 2006), which we predict would make them a prime target
for productive infection in the gut.
The ability to deﬁne SIV infected cells in vivo allowed us to
study several aspects of the preferred targets of SIV infection. Our
experiments conﬁrm the high speciﬁcity of SIV for CD28þCD95þ
central memory T cells (Brenchley et al., 2004; Heeregrave et al.,
2009; Schnittman et al., 1990; Willerford et al., 1990). Interest-
ingly, CD28CD95þ cells were more likely to be infected from the
CD3CD4 infected population than the CD3þCD4þ infected
population, indicating that effector memory T cells were over-
represented among infected cells with down-regulated CD3 and
CD4. However, HIV and SIV are also known to down-regulate
surface CD28 (Bell et al., 2001; Swigut et al., 2001), at least
in vitro. Therefore the true identity of these CD3CD4 infected
cells that are CD28CD95þ cells requires further investigation.
It has been widely predicted that HIV and SIV-infected cells are
more likely to be activated since these viruses replicate more
efﬁciently in activated cells in vitro (McDougal et al., 1985; Nabel
and Baltimore, 1987). Interestingly, we did not detect higher
levels of productively-infected cells in the CD25þ/CD69þ
(activated) blood lymphocyte population, with the vast majority
of p27þ cells lying within the unactivated cells. However we
found higher levels of infected cells in activated, compared to
unactivated lymph node lymphocytes, consistent with preferen-
tial HIV-1 infection of activated CD4þ T cells in lymph nodes
(Meditz et al., 2011). The study of other activation markers such
as HLA-DR, CD38 and Ki67 might be useful to fully characterise
activation of infected cells in future studies.
Mucosal homing T cells are important in HIV/SIV pathogenesis
both since they are rapidly depleted during HIV/SIV infection
(Arthos et al., 2008; Kader et al., 2009) and due to their role
in mucosal immunity (Czerkinsky and Holmgren, 1994). The
mucosal homing integrin a4b7 may act as a co-receptor for HIV
infection allowing preferential targeting of a4b7-expressing cells
by HIV/SIV infection (Cicala et al., 2009). In previous studies, the
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correlated with the depletion of gut CD4 T cells in SIV infection
(Kader et al., 2009). We were not able to conﬁrm high level
targeting of a4b7-expressing lymphocytes in vivo. Although the
b7-high expressing blood lymphocytes were modestly enriched
for p27þ cells, the majority of infected cells were in b7Lo or b7
cells. It is possible that the a4b7-high expressing blood lympho-
cytes rapidly die after infection and cannot be visualised, however
our studies were conducted during acute infection and other
p27þ populations were readily detectable. Of course, a different
picture may be observed in future studies of gut mucosal
lymphocytes.
The ﬂow-based p27 Gag protein assay detects viral proteins
and as there are no other viral protein assays that can be
performed on a per cell basis, it is difﬁcult to assess the sensitivity
of the assay directly. It is likely that the substantial level of
binding required to detect p27 protein contributes to the detec-
tion rate of 0.4% of T cells being p27þ during acute infection
found by both us and other groups that have used the same assay
(Friedrich et al., 2010; Reynolds et al., 2010). Thus we predict that
this ﬂow assay for p27þ cells detects cells with highly productive
infection. This is consistent with our ﬁnding that infected cells
undergoing CD3 and CD4 down-regulation have higher ﬂuores-
cent intensity of p27 staining. PCR based assays to detect viral
DNA or RNA are likely to be more sensitive (detecting single
copies) but do not assess whether the nucleic acids actually lead
to highly efﬁcient protein production. For example, Mattapillil
(2005) showed, by sorting small numbers of CD4þ T lymphocytes
from macaques during acute SIV infection, that 30–60% of all
CD4þ T cells contained Gag DNA. However, on average the cells
contained only 1.5 copies of SIV DNA per cell across both PBMC
and lymph node cells suggesting that most cells do not have
highly productive infections even though viral nucleic acids can
be detected.
In summary, down-regulation of both CD3 and CD4 molecules
appears to be common in SIV-infected cells in vivo, such that a
high proportion of productively-infected cells in both blood and
lymph nodes do not initially appear to be CD3þCD4þ T cells.
It will be of interest to repeat our ﬁndings in humans with
acute HIV infection, but this work provides a cautionary note to
researchers only studying CD4 and CD3-expressing cells for HIV/SIV
infection.Materials and methods
Macaques and SIV infections
Seventeen pigtail macaques (Macaca nemestrina) were sourced
from the Australian National Macaque Breeding Facility that were
free from simian retrovirus D and tuberculosis and had not been
previously infected with SIV. Fifteen macaques were infected with
SIVmac251 104 TCID50 intravaginally via atraumatic instillation
as previously described (Kent et al., 2005) and two with 600 mg of
SIVmac239 proviral DNA IM as previously described (Kent et al.,
2001; Loh et al., 2008). Animals were sedated with Ketamine
during all procedures, including the serial blood and lymph node
biopsies. The relevant institutional animal ethics committees
approved all studies.
Antibodies
Anti p27-FITC (clone 55-2F12; NIH AIDS Research and Refer-
ence Reagent Programme) was kindly provided by Dr Nancy
Wilson, University of Wisconsin (Friedrich et al., 2010). Antibo-
dies to phenotype infected cells were raised to: CD2 Per-CPCy5.5(BD (San Jose, CA), clone RPA-2.10, cat. 560643), CD3 Paciﬁc blue
(BD, clone SP34-2, cat. 558124), CD3 AF700 (BD, clone, SP32-4,
cat. 557917), CD4 AF700 (BD, clone L200, cat. 560836), CD4 V450
(BD, clone L200, cat. 550811), CD4 PerCP (BD, clone L200, cat.
550631), CD5 APC (Invitrogen, Carlsbad, CA clone 5D7, cat.
MHCD0505), CD8 Pe-Cy7 (BD, clone SK1, cat. 335787), CD8 Pac
blue (BD, clone RPA-T8, cat. 558207), CD8 APC-H7 (BD, clone SK1,
cat. 641400), CD14 PE-Cy7 (BD, clone M5E2, cat. 557742), CD14
APC-H7 (BD, clone MjP9, cat. 560270), CD16 PE (BD, 560995,
clone 3G8), CD20 PE-Cy7(BD, clone L27, cat. 335793), CD25-APC
(eBioscience (San Diego, CA), clone BC96, cat. 17-0259-42), CD28
PerCP-Cy5.5 (BD, clone L293, cat. 337181), CD56 PE (BD, clone
B159, cat. 555516), CD69 APC (BD, clone L78, cat. 340560), biotin-
conjugated CD95, (BD, clone DX2, cat. 555672), Mattapi integrin
APC (BD, clone FIB504, cat. 551082).
Preparation of lymph node cells
Inguinal lymph nodes were surgically removed 14 days
after infection from the two anaesthetised SIVmac251-infected
macaques and stored on ice. They were cut into approximate
2 mm pieces with scissors and carefully ground into a slurry using
a 5 ml syringe plunger (Terumo, Somerset, NJ) and washed
through a 70 mm ‘‘Cell Strainer’’ ﬁlter (BD) with RPMI media
(Gibco, Invitrogen). Cell numbers were determined using an
ACT DIFF Coulter Counters (Beckman Coulter, Brea, CA).
Preparation and storage of peripheral blood mononuclear cells
(PBMCs)
Fresh blood, stored in heparinised or EDTA-coated vials was
carefully layered over 95% Ficoll-Paque PLUSTM (GE Healthcare,
Buckinghamshire, England)/5% water (V/V) and centrifuged at
1000 g for 25 min at room temperature. The interface was
recovered using a transfer pipette and washed with RPMI media
and centrifuged at 500 g for 5 min at room temperature. Cell
counts were performed using an ACT DIFF Coulter Counters.
PBMCs were resuspended in a solution of 90% FCS (Bovogen
Biologicals, East Keilor, Victoria, Australia)/10% (v/v) dimethyl-
sulphoxide (Sigma-Aldrich St. Louis, MO) at a concentration of
5106 cells/ml and frozen in a ‘‘Mr Frosty’’ freezing container
(ThermoFisher Scientiﬁc) at 80 1C before long-term storage in
liquid nitrogen.
Cell staining for ﬂow cytometry
Fresh, heparinised, whole blood (200 ml) or inguinal lymph
node cell preparations were surface-stained for CD3, CD8 and
CD4 at room temperature for 20 min. For selected experiments
antibodies T cell memory markers (CD28 and CD95), activation
markers (CD25 and CD69), B cells (CD20), monocytes (CD14) or
HLA-ABC, and the mucosal homing marker b7 and were also
included. To detect biotinylated CD95 staining, a streptavidin-PE
conjugate was used at 25 ng/ml for 30 min at room temperature.
Red blood cells were lysed using 1 FACsTM Lysing Solution (BD)
or OptiLyses C (Beckman Coulter) according to the manufac-
turer’s guidelines and white blood cells were then permeabilised
using 1 FACsTM Permeabilising Solution (BD). Permeabilised
cells were incubated with 0.125 mg in 50 ml anti-p27-FITC, at
room temperature for 30 min before washing with 2 ml PBS and
ﬁxing with 1% paraformaldehyde (Polysciences Inc., Warrington,
PA) or Stabilizing Fixative (BD).
Frozen PBMCs (1 ml at 5106 cells/ml) were rapidly thawed
in a 37 1C water-bath then incubated for 10 min in 3 ml RPMI/
10%FCS 66 U/ml DNase in a 37 1C water-bath, followed by wash-
ing in the same media. PBMCs were incubated with LIVE/DEAD
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30 min followed by a wash in 1 PBS/0.5% (w/v) BSA/2 mM EDTA.
PBMCs were then surface-stained for CD2, CD3, CD4, CD5, CD8,
CD20 and a combination of CD16a and CD56 which together mark
NK cells in macaques, as well as some CD16 positive granulocytes
and CD56 positive monocytes (Reeves et al., 2010). These cells
were then ﬁxed in 1 PBS/1% (v/v) formaldehyde for 10 min,
washed in 2 ml PBS then subject to permeabilisation as described
above. Permeabilised cells were incubated with 0.0416 mg of anti-
p27-FITC for 30 min at room temperature followed by washing
and ﬁxing as described above.
Flow cytometry
Acquisition was performed on a FACSCanto II or LSRII ﬂow
cytometer (BD) according to the manufacturer’s instructions and
data were analysed using FlowJo Version 9.2 (TreeStar, Ashland,
USA). Flow cytometer compensation was set up using the auto-
compensation function using calibrateTM beads (BD) for FITC,
PE and APC and CompBead PLUS anti-rat Ig k beads (BD) stained
singly with individual antibodies used in the experimental
samples. Mononuclear cells were gated according to scatter
properties and aggregates excluded. CD8 negative cells that were
CD3-positive, CD3-low and CD3-negative were then examined for
the presence of intracellular p27 and surface CD4. T cells were
further identiﬁed by their expression of CD2 and CD5, monocytes
by CD14, B cells by CD20, NK cells by both CD16 and CD56, naı¨ve,
central or effector memory T cells using CD28 and CD95, activated
cells by CD25 and CD69, and T-cells expression the mucosal
homing integrin a4b7 were also detected.
Determination of viral load
SIV viral load was determined as previously described, with
some modiﬁcations (Leutenegger et al., 2001). Fresh, EDTA-treated
whole blood, was centrifuged at 950 g for 12 min at room tem-
perature. Plasma was recovered from the top layer and stored at
80 1C. RNA was isolated from 140 or 280 ml plasma using a
QIAamp Viral RNA kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. SIV viral load was determined by qPCR
by a Superscripts III RT-PCR reaction (Invitrogen) using TaqMans
Universal PCR Mastermix (Applied Biosystems Inc, Foster City, CA)
according to the manufacturers’ instructions. An 81 bp product in
the SIV GAG gene was ampliﬁed using the primers 50-CAACAGGCT-
CAGAAAA-30(forward) and 50-TTTTCTGAGCCTGTTG-30 (reverse)
and detected using the Taqmans probe 50-ATAATACTGTCTGCGT-
CATCTGGTG-30 using a Mastercyclers ep Realplex4 instrument
(Eppendorf, Hamburg, Germany). Sample viral load was deter-
mined using a standard curve made from in vitro-transcribed SIV
RNA. To make the standards, a 670nt GAG RNA product was
in vitro-transcribed using a MEGAscripts T7 kit (Ambion, Inc,
Austin, TX), treated with TURBOTM DNase (Ambion) and RNA of
the correct size was quantiﬁed using an Agilent 2100 Bioanalyser
(Agilent, Santa Clara, CA). Negative controls were included where
the reverse transcriptase enzyme was omitted.
Statistical analyses
Statistical analyses were performed using SPSS version 18
software (IBM, Armonk, NY, USA). Data in Fig. 1D and E were
log10-transformation prior to analysis by one-way ANOVA in
conjunction with Tukey’s post-hoc test. After transformation,
the data did not pass Levene’s test for equal variances but were
close to p¼0.05, therefore the a level for one-way ANOVAs was
set at 0.01. Data in Fig. 2A were analysed by a Friedman test,
followed by Wilcoxon Signed Rank tests. These non-parametrictests were necessary as many of the values were 0. A Bonferroni
adjustment was used to set a new a level of 0.017 for these
analyses. Data in Fig. 6B were analysed by a Kruskal Wallis test.Acknowledgments
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